NCT00616980 - Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

April 30, 2010

Study Completion Date

August 31, 2010

Conditions

Peripheral Artery DiseasePeripheral Vascular DiseaseCritical Limb Ischemia

Interventions

BIOLOGICAL

CD34-positive cells

BIOLOGICAL

CD34-positive cells

BIOLOGICAL

Saline and 5% autologous plasma

Trial Locations (12)

10029

Mount Sinai School of Medicine Division of Vascular Surgery, New York

27514

University of North Carolina at Chapel Hill, Chapel Hill

32605

Florida Research Network LLC, Gainsville

32806

Orlando Regional Medical Center, Orlando

35211

Cardiology, PC, Birmingham

44106

University Hospitals of Cleveland, Case Medical Center, Cleveland

52242

University of Iowa Hospitals and Clinics, Iowa City

53215

Comprehensive Cardiovascular Care St. Luke's Medical Center, Milwaukee

60611

Northwestern University, Chicago

84132

University of Utah-Vascular Surgery Division, Salt Lake City

98122

Swedish Medical Center, Seattle

02114

Massachusetts General Hospital, Boston

All Listed Sponsors

collaborator

Baxter Healthcare Corporation

INDUSTRY

lead

Losordo, Douglas, M.D.

INDIV